Edwards Lifesciences’ artificial aortic valve technology opens the way for innovative heart surgery, which promises to reduce costs, as well as patient recovery time.
Director, Research Associate Program
Sands Capital (2013-2014)
Arlington, VA Sr. Research Associate
Credit Suisse Securities Private Fund Group (2007-2011)
New York, NY Associate
John Hopkins University - Pre-Medical Post-Baccalaureate Program (2012)
University of Virginia - BS, McIntire School of Commerce and Philosophy (2007)
Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines rigorous fundamental analysis with creative thinking to identify high-quality growth businesses that are creating the future. Through strategies designed to concentrate investment in these businesses, we serve the long-term growth objectives of institutions and fund sponsors in more than 40 countries.
An independent, staff-owned firm based in the Greater Washington, DC area, Sands Capital managed more than USD $68 billion in client assets as of December 31, 2020.
© 2021 Sands Capital Management. All Rights Reserved.
For institutional and professional investors only.